Grand Junction, Colorado Clinical Trials

A listing of Grand Junction, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

Research Site
 (1.0 away) Contact site
  • 0 views
  • 27 Jul, 2022
  • +134 other locations
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.

vaccination
prenatal
lower respiratory tract infection
Accepts healthy volunteers
Dino-Peds
 (0.8 away) Contact site
  • 1100 views
  • 09 Aug, 2022
  • +431 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

carboplatin
pembrolizumab
paclitaxel
crizotinib
nivolumab
Saint Mary's Hospital and Regional Medical Center
 (1.0 away) Contact site
  • 1154 views
  • 08 Aug, 2022
  • +1028 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

carboplatin
hepatitis b
immunosuppressive
hepatitis c virus
aptt
Saint Mary's Hospital and Regional Medical Center
 (0.8 away) Contact site
  • 322 views
  • 09 Aug, 2022
  • +769 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

absolute neutrophil count
immunosuppressive
stage iii colon cancer
hiv viral load
corticosteroids
Grand Valley Oncology
 (1.0 away) Contact site
  • 1145 views
  • 08 Aug, 2022
  • +545 other locations
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system …

Saint Mary's Hospital and Regional Medical Center
 (1.0 away) Contact site
  • 0 views
  • 06 May, 2022
  • +440 other locations
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important …

mitomycin
ct scan
biomarker analysis
tumor cells
cardiac arrhythmia
Saint Mary's Hospital and Regional Medical Center
 (1.0 away) Contact site
  • 433 views
  • 04 Jul, 2022
  • +937 other locations
Excimer Laser Trabeculostomy Glaucoma Treatment Study (ELTGTS)

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG) undergoing cataract surgery

ELIOS Vision Clinical Site
 (0.8 away) Contact site
  • 6 views
  • 28 Jun, 2022
  • +17 other locations
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Study

This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been completely removed by surgery (resected). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may …

Saint Mary's Hospital and Regional Medical Center
 (1.0 away) Contact site
  • 22 views
  • 22 Jul, 2022
  • +402 other locations
Testing the Effects of Early Treatment With Venetoclax and Obinutuzumab Versus Delayed Treatment With Venetoclax and Obinutuzumab for Newly Diagnosed Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Do Not Have Symptoms, the EVOLVE CLL/SLL Study

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer …

monoclonal antibodies
cancer
TP53
platelet count
lymphoma
Grand Valley Oncology
 (1.0 away) Contact site
  • 16 views
  • 22 Jul, 2022
  • +233 other locations